GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Alar Pharmaceuticals Inc (ROCO:6785) » Definitions » Price-to-Operating-Cash-Flow

Alar Pharmaceuticals (ROCO:6785) Price-to-Operating-Cash-Flow : 36.70 (As of Mar. 03, 2025)


View and export this data going back to 2020. Start your Free Trial

What is Alar Pharmaceuticals Price-to-Operating-Cash-Flow?

As of today (2025-03-03), Alar Pharmaceuticals's share price is NT$149.00. Alar Pharmaceuticals's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Sep. 2024 was NT$4.06. Hence, Alar Pharmaceuticals's Price-to-Operating-Cash-Flow Ratio for today is 36.70.

The historical rank and industry rank for Alar Pharmaceuticals's Price-to-Operating-Cash-Flow or its related term are showing as below:

ROCO:6785' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 28.18   Med: 54.31   Max: 101.27
Current: 36.7

During the past 7 years, Alar Pharmaceuticals's highest Price-to-Operating-Cash-Flow Ratio was 101.27. The lowest was 28.18. And the median was 54.31.

ROCO:6785's Price-to-Operating-Cash-Flow is ranked worse than
77.91% of 697 companies
in the Drug Manufacturers industry
Industry Median: 16.6 vs ROCO:6785: 36.70

Alar Pharmaceuticals's Cash Flow from Operations per share for the three months ended in Sep. 2024 was NT$-0.56. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Sep. 2024 was NT$4.06.

During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Alar Pharmaceuticals was 97.70% per year.

During the past 7 years, Alar Pharmaceuticals's highest 3-Year average Operating Cash Flow per Share Growth Rate was 33.70% per year. The lowest was 0.10% per year. And the median was 9.80% per year.


Alar Pharmaceuticals Price-to-Operating-Cash-Flow Historical Data

The historical data trend for Alar Pharmaceuticals's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alar Pharmaceuticals Price-to-Operating-Cash-Flow Chart

Alar Pharmaceuticals Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Operating-Cash-Flow
Get a 7-Day Free Trial - - - - 28.98

Alar Pharmaceuticals Quarterly Data
Dec17 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Price-to-Operating-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 75.46 28.98 61.61 55.30 44.70

Competitive Comparison of Alar Pharmaceuticals's Price-to-Operating-Cash-Flow

For the Drug Manufacturers - Specialty & Generic subindustry, Alar Pharmaceuticals's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Alar Pharmaceuticals's Price-to-Operating-Cash-Flow Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Alar Pharmaceuticals's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Alar Pharmaceuticals's Price-to-Operating-Cash-Flow falls into.



Alar Pharmaceuticals Price-to-Operating-Cash-Flow Calculation

Alar Pharmaceuticals's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio=Share Price/Cash Flow from Operations per share (TTM)
=149.00/4.06
=36.70

Alar Pharmaceuticals's Share Price of today is NT$149.00.
Alar Pharmaceuticals's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$4.06.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio=Market Cap/Cash Flow from Operations

Alar Pharmaceuticals Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Alar Pharmaceuticals's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Alar Pharmaceuticals Business Description

Traded in Other Exchanges
N/A
Address
No. 19, Keyuan Road, Rm. 312, 3rd Floor, Xitun District, Taichung, TWN, 407
Alar Pharmaceuticals Inc is a drug development company. It focuses on developing long-acting release drug products for CNS disorders and chronic diseases, which mainly include opioid use disorder, chronic pain, and depressive disorder. These chronic diseases not only cause long-term burdens to the patients and their families but also consume huge social costs.

Alar Pharmaceuticals Headlines

No Headlines